LSX Nordic Congress 2019
The LSX Nordic Congress is a high-calibre, senior executive conference and partnering event providing the education, strategies, solutions, and contacts that life science companies need to enable more effective investment, business planning and partnering within their businesses.
The Nordic region has long produced world-leading science and innovation and, now in its second year, the LSX Nordic Congress will be all about showcasing this innovation, both of the region’s industry leaders but also through start-ups and technology innovators driving the future of healthcare.
Nasdaq Nordic is one of the leading hubs for life sciences in Europe, strengthened further by an active IPO market in the last few years, and we’re delighted to be working again with Nasdaq as hosts of the congress. But this is not just for listed companies. This is the executive strategy, investment and partnering event for companies of all sizes, addressing challenges in their ongoing funding, growth, development and internationalisation.
With our growing international community of investors and pharma, our aim and mission is to bring investors to the Nordic region and connect Nordic executives with capital and partners, as well as peer-to-peer knowledge exchange.
Date: 28-29 August, 2019
Venue: Nasdaq Offices, Stockholm, Sweden
MVA members get a 15% discount on their registration fee by using the following registration code: mva15
Across the two days, you’ll see panel discussions, auxiliary forums and have presentation opportunities. These presentations are the best way for a company to gain visibility and we produce them a corporate video for post event outreach and we’re also offering all early signups the opportunity to publish a 500-1000 word content piece on our blog.
All Nordic biotech and medtech companies are welcome and will get access to 70+ pan European investors. Almost 30 investors have already confirmed their attendance.